Cargando…

Thrombospondin 1 and cathepsin D improve prostate cancer diagnosis by avoiding potentially unnecessary prostate biopsies

OBJECTIVES: To investigate and further validate if two novel cancer‐related glycoproteins, discovered by a genetic‐guided proteomics approach, can distinguish benign disease from prostate cancer (PCa) in men with enlarged prostates. PATIENTS AND METHODS: A retrospective study was performed that incl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Steuber, Thomas, Tennstedt, Pierre, Macagno, Annalisa, Athanasiou, Alcibiade, Wittig, Anja, Huber, Ramy, Golding, Bruno, Schiess, Ralph, Gillessen, Silke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Urological Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379977/ https://www.ncbi.nlm.nih.gov/pubmed/30216634 http://dx.doi.org/10.1111/bju.14540

Ejemplares similares

Analytical performance of thrombospondin-1 and cathepsin D immunoassays part of a novel CE-IVD marked test as an aid in the diagnosis of prostate cancer
por: Macagno, Annalisa, et al.
Publicado: (2020)

A novel serum biomarker quintet reveals added prognostic value when combined with standard clinical parameters in prostate cancer patients by predicting biochemical recurrence and adverse pathology
por: Athanasiou, Alcibiade, et al.
Publicado: (2021)

Development and clinical testing of individual immunoassays for the quantification of serum glycoproteins to diagnose prostate cancer
por: Endt, Kathrin, et al.
Publicado: (2017)

Development and validation of a novel multivariate risk score to guide biopsy decision for the diagnosis of clinically significant prostate cancer
por: Klocker, Helmut, et al.
Publicado: (2020)

A Neural Network Model Combining [-2]proPSA, freePSA, Total PSA, Cathepsin D, and Thrombospondin-1 Showed Increased Accuracy in the Identification of Clinically Significant Prostate Cancer
por: Gentile, Francesco, et al.
Publicado: (2023)

Disseminated Intravascular Coagulation With Excessive Fibrinolysis Following Diagnostic Prostatic Biopsy for Prostate Cancer
por: Ghallab, Muhammad, et al.
Publicado: (2022)

A Comparative Study: Has MRI-guided Fusion Prostate Biopsy Changed the Prostate-specific Antigen Gray-zone Range?
por: Sönmez, Gökhan, et al.
Publicado: (2019)

Active surveillance for low-risk prostate cancer: well established, yet avoided?
por: Sosnowski, Roman, et al.
Publicado: (2022)

Does a novel diagnostic pathway including blood-based risk prediction and MRI-targeted biopsies outperform prostate cancer screening using prostate-specific antigen and systematic prostate biopsies? - protocol of the randomised study STHLM3MRI
por: Nordström, Tobias, et al.
Publicado: (2019)

Focal Cryoablation of the Prostate: Primary Treatment in 163 Patients With Localized Prostate Cancer
por: Khan, Anwar, et al.
Publicado: (2023)

Clinical and Histopathological Characteristics of Prostate Cancer Patients Taken to Palliative Transurethral Prostate Resection
por: Rojas-Manrique, Juan P, et al.
Publicado: (2019)

Contemporary Management of Chronic Prostatitis
por: Khattak, Ahmed S, et al.
Publicado: (2021)

Aquablation versus holmium laser enucleation of the prostate in the treatment of benign prostatic hyperplasia in medium-to-large-sized prostates (ATHLETE): protocol of a prospective randomised trial
por: Müllhaupt, Gautier, et al.
Publicado: (2021)

A Prospective Study and Single-Center Experience: Effectivity of Fusion Prostate Biopsy in Biopsy-Naïve Patients
por: Demirtaş, Türev, et al.
Publicado: (2021)

Correlation of Postoperative Outcomes According to the Amount of Prostatic Tissue Removed in Patients Undergoing Transurethral Resection of the Prostate
por: Turgut, Ömer, et al.
Publicado: (2023)

Outpatient transperineal prostate biopsy under local anaesthesia is safe, well tolerated and feasible
por: Hong, Anne, et al.
Publicado: (2022)

An optimized prostate biopsy strategy in patients with a unilateral lesion on prostate magnetic resonance imaging avoids unnecessary biopsies
por: Jager, Auke, et al.
Publicado: (2022)

Hemophagocytic Lymphohistiocytosis Secondary to Prostatic Adenocarcinoma
por: Rajapakse, Pramuditha, et al.
Publicado: (2021)

Prostate MRI versus PSA screening for prostate cancer detection (the MVP Study): a randomised clinical trial
por: Nam, Robert, et al.
Publicado: (2022)

The Predictive Value of Prostate-Specific Antigen Density: A Retrospective Analysis of Likert 3 Multiparametric MRI of the Prostate
por: Feyisetan, Oladapo, et al.
Publicado: (2023)

Use of MS-GUIDE for identification of protein biomarkers for risk stratification of patients with prostate cancer
por: Goetze, Sandra, et al.
Publicado: (2022)

A Single-center Experience: Does MRI-guided Target Prostate Biopsy Meet Expectations?
por: Demirtaş, Türev, et al.
Publicado: (2019)

Protocol of a multicentre randomised controlled trial assessing transperineal prostate biopsy to reduce infectiouscomplications
por: Hu, Jim, et al.
Publicado: (2023)

Leptomeningeal Metastases in Hormone Refractory Prostate Cancer
por: Ng, Jessica Y, et al.
Publicado: (2018)

Prostate Cancer Support Groups: The Unadvertised Camaraderie
por: Santarelli, Shana, et al.
Publicado: (2021)

Metastatic Prostate Adenocarcinoma: A Rare Presentation
por: Rodriguez, Pierre, et al.
Publicado: (2022)

Decision analytic cost-effectiveness model to compare prostate cryotherapy to androgen deprivation therapy for treatment of radiation recurrent prostate cancer
por: Boyd, Kathleen A, et al.
Publicado: (2015)

Monopolar Transurethral Resection of Prostate for Benign Prostatic Hyperplasia in Patients With and Without Preoperative Urinary Catheterization: A Prospective Comparative Study
por: Adhikari, Baikuntha, et al.
Publicado: (2021)

Primary Non-Hodgkins Lymphoma of the prostate presenting as haematuria
por: Rizvi, Fahad A, et al.
Publicado: (2011)

Malignant Degeneration to Leiomyosarcoma of the Anorectal Junction Invading the Prostate
por: Perrotti, Gabrielle, et al.
Publicado: (2021)

Systematic Review of Focal and Salvage Cryotherapy for Prostate Cancer
por: Chin, Yew Fung, et al.
Publicado: (2022)

What is the risk of prostate cancer mortality following negative systematic TRUS-guided biopsies? A systematic review
por: Kawa, Sandra Miriam, et al.
Publicado: (2020)

Evaluating the diagnostic role of in‐bore magnetic resonance imaging guided prostate biopsy: a single‐centre study
por: Furrer, Marc A., et al.
Publicado: (2022)

Using Google Trends and Twitter for Prostate Cancer Awareness: A Comparative Analysis of Prostate Cancer Awareness Month and Breast Cancer Awareness Month
por: Johnson, Bradley S, et al.
Publicado: (2021)

ReIMAGINE Prostate Cancer Screening Study: protocol for a single-centre feasibility study inviting men for prostate cancer screening using MRI
por: Marsden, Teresa, et al.
Publicado: (2021)

Non-Invasive Predictors of Response to Tamsulosin for Benign Prostatic Obstruction
por: Shoaib, Mohammad, et al.
Publicado: (2021)

Rezum Therapy for Benign Prostatic Hyperplasia: Dubai’s Initial Experience
por: Rowaiee, Rashed, et al.
Publicado: (2021)

A Scoping Review of the Management of Benign Prostate Hyperplasia in Africa
por: Zubair, Abdulahi, et al.
Publicado: (2022)

Antibody-Drug Conjugates in Prostate Cancer: A Systematic Review
por: Sardinha, Mariana, et al.
Publicado: (2023)

Exploring the Use of Artificial Intelligence and Robotics in Prostate Cancer Management
por: Arigbede, Olumide, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5p0n51kc1dg0p4gcv56nrmp69j